OCA

Octagon Capital Advisors Portfolio holdings

AUM $904M
1-Year Est. Return 737.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+737.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$904M
AUM Growth
+$105M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$31.9M
2
+$22.6M
3
+$21.8M
4
IRON icon
Disc Medicine
IRON
+$18.7M
5
AKTS
Aktis Oncology
AKTS
+$18.7M

Top Sells

1
+$27.2M
2
+$22.1M
3
+$19.4M
4
TRVI icon
Trevi Therapeutics
TRVI
+$14.9M
5
PHVS icon
Pharvaris
PHVS
+$13.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
1
Dianthus Therapeutics
DNTH
$4.46B
$163M 18.08%
1,946,667
-470,000
COGT icon
2
Cogent Biosciences
COGT
$5.6B
$90.5M 10.01%
2,350,000
ABVX
3
Abivax
ABVX
$5.78B
$75.4M 8.34%
677,000
-79,000
ALMS
4
Alumis Inc
ALMS
$2.55B
$62.4M 6.9%
2,830,700
+300,000
DFTX
5
Definium Therapeutics
DFTX
$2.49B
$46.1M 5.1%
2,440,000
+210,000
AVBP icon
6
ArriVent BioPharma
AVBP
$1.39B
$45.5M 5.03%
1,971,054
TSHA icon
7
Taysha Gene Therapies
TSHA
$1.64B
$39.6M 4.38%
8,859,911
KYMR icon
8
Kymera Therapeutics
KYMR
$5.86B
$35.4M 3.92%
425,000
-110,000
MIRM icon
9
Mirum Pharmaceuticals
MIRM
$5.62B
$31.3M 3.46%
+338,900
BIOA
10
BioAge Labs
BIOA
$735M
$30.6M 3.38%
1,748,000
+150,000
CNTA
11
Centessa Pharmaceuticals
CNTA
$6.17B
$29.8M 3.3%
750,000
KALV icon
12
KalVista Pharmaceuticals
KALV
$1.43B
$29.2M 3.23%
1,450,000
+176,667
XENE icon
13
Xenon Pharmaceuticals
XENE
$5.06B
$28.5M 3.15%
+490,000
TERN
14
DELISTED
Terns Pharmaceuticals
TERN
$27.9M 3.09%
+530,000
OCUL icon
15
Ocular Therapeutix
OCUL
$1.82B
$26.8M 2.97%
3,166,600
+543,000
PALI icon
16
Palisade Bio
PALI
$323M
$18M 1.99%
10,276,317
+708,419
TRVI icon
17
Trevi Therapeutics
TRVI
$1.92B
$17.7M 1.96%
1,485,000
-1,330,000
IRON icon
18
Disc Medicine
IRON
$2.6B
$17.3M 1.91%
+270,000
AKTS
19
Aktis Oncology
AKTS
$1.12B
$17.2M 1.9%
+960,847
CNTX icon
20
Context Therapeutics
CNTX
$222M
$13.8M 1.52%
+5,250,000
DTIL icon
21
Precision BioSciences
DTIL
$163M
$12.3M 1.36%
2,236,732
+318,737
DBVT
22
DBV Technologies
DBVT
$1.08B
$12M 1.33%
574,200
UNCY icon
23
Unicycive Therapeutics
UNCY
$193M
$6.58M 0.73%
1,000,000
BBOT
24
BridgeBio Oncology
BBOT
$662M
$6.44M 0.71%
719,000
-324,110
LXEO icon
25
Lexeo Therapeutics
LXEO
$354M
$6.31M 0.7%
1,100,000
-625,000
1
2